Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study

Fig. 2

Progression-free Survival According to Risk Factors (RFs). (a) Low insulin (i.e. below CART cut-off), (b) high osteopontin (OPN), (c) high hepatocyte growth factor (HGF) (i.e. above CART cut off), and (d) low C-Peptide (i.e. below the median) each represent a risk factor (RF) for progression. (e) PFS curves were generated for patients falling in 3 separate risk groups: 0, 1, 2 and 3 RFs. No patients had 4 RF

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us